Pfizer, Moderna and BioNTech
BioNTech has signed two new deals with manufacturers to produce lipids at scale, while Moderna's supplier told Reuters it has recently doubled its monthly production of the key ingredients.
The Pfizer/BioNTech bivalent COVID-19 vaccine (Original and Omicron BA.4/BA.5) has the FDA’s EUA for use in individuals 5 years and over as a single booster dose administered at least two months ...
In multiple independent studies, significantly lower antibody levels and more vaccine breakthrough infections have been detected in the Pfizer/BioNTech-vaccinated population. These could be ...
3mon
Health on MSNShould Kids Get the COVID-19 Vaccine?Children shouldn't receive the Moderna or Pfizer-BioNTech vaccines if they've had a severe allergic reaction to the ...
The post claims that Pfizer just released a list of side effects of its COVID-19 vaccine. It then proceeds to enumerate over 40 alleged side effects, including heart failure, liver damage ...
It's not the first time Pfizer and BioNTech have been accused of patent infringement with Comirnaty, as another mRNA COVID-19 vaccine developer – CureVac – filed a suit in Germany last month ...
In addition, Pfizer pays an attractive dividend, making the stock a favorite of income-seeking investors. This COVID-19 vaccine remains BioNTech's primary revenue source for now. However ...
BioNTech lowers full-year revenue outlook on COVID-19 seasonality, inventory write-downs November 4, 2024 Pfizer CEO Albert Bourla, under pressure from activist hedge fund Starboard Value ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results